Data Make It Clear: SGLT2 Inhibitors Can Be Used in Most Common Kidney Diagnoses, Says Dr William G. Herrington

Data shows sodium-glucose cotransporter-2 (SGLT2) inhibitors are efficacious and can be used in almost all common kidney diagnoses, explained William G. Herrington, MD, MA, MBBS, Nuffield Department of Population Health, University of Oxford.

Related Keywords

Williamg Herrington , ,Nuffield Department Of Population Health ,University Of Oxford ,Nuffield Department ,Population Health ,Oxford Kidney ,Kidney Week ,Diabetes ,Kidney Disease ,Sglt2 Inhibitors ,Empagliflozin ,Dapagliflozin ,